Potential use of salivary TNF-α as a vaccine-induced pain biomarker in people with cerebral palsy and communication disorders
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0308386 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Álvaro Sabater-Gárriz und 3 weiteren Autor:innen. Beteiligte Einrichtung: Balearic ASPACE Foundation, Marratxí, Spain. Hauptthemen laut MEDLINE: Cerebral Palsy, Saliva, Biomarkers, Pain. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministerio de Ciencia e Innovación.
Abstract (Originalsprache)
Background
Pain in people with cerebral palsy (CP) has been classically underestimated and poorly treated, particularly in individuals with impaired communication skills.
Objective
To analyze changes in different salivary metabolites and pain behavior scales after a painful procedure in adults with CP and adults with typical development.
Methods
Salivary levels of sTNF-α, sIgA, Cortisol, FRAP, ADA and Alpha Amylase, as well as 3 observational pain scales (Wong-Baker, Non-Communicating Adults Pain Checklist and Facial Action Coding System) were assessed before and after an intramuscular injection in 30 Individuals with CP and 30 healthy controls. Video recording of face expression was performed during the procedure for offline analysis.
Results
Pain in subjects with CP was higher than in healthy controls after the intramuscular injection as displayed by observational scales. sTNF-α experienced a significant post-stimulus increase in both groups and that increase shows a tendency to correlate with the observational scales scores. Other biomarkers classically associated with stress (cortisol, Alpha Amylase) remain stable. Conclusion sTNF-α might be a promising pain indicator. Further research using controlled painful stimuli of greater intensity and pain self-reports, would be necessary to better understand its use as a pain biomarker.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Balearic ASPACE Foundation, Marratxí, Spain.
- Research Institute on Health Sciences (IUNICS-IdISBa), University of the Balearic Islands, Palma de Mallorca, Spain.
- Department of Nursing and Physiotherapy, University of the Balearic Islands, Palma de Mallorca, Spain.
- Interdisciplinary Laboratory of Clinical Analysis, Interlab-UMU, Regional Campus of International Excellence Campus Mare Nostrum, University of Murcia, Murcia, Spain.
ORCID-Profile: Álvaro Sabater-Gárriz, Inmaculada Riquelme
Förderung
- Ministerio de Ciencia e Innovación
Zitieren
APA
Sabater-Gárriz, Á., Cerón, J. J., Montoya, P., & Riquelme, I. (2024). Potential use of salivary TNF-α as a vaccine-induced pain biomarker in people with cerebral palsy and communication disorders. PLOS ONE. https://doi.org/10.1371/journal.pone.0308386
Vancouver
Sabater-Gárriz Á, Cerón JJ, Montoya P, Riquelme I. Potential use of salivary TNF-α as a vaccine-induced pain biomarker in people with cerebral palsy and communication disorders. PLOS ONE. 2024. doi:10.1371/journal.pone.0308386
BibTeX
@article{SabaterGrriz2024,
author = {Sabater-Gárriz, Álvaro and Cerón, José Joaquín and Montoya, Pedro and Riquelme, Inmaculada},
title = {Potential use of salivary TNF-α as a vaccine-induced pain biomarker in people with cerebral palsy and communication disorders},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0308386}
}
EUVIMED